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Three more isolates of Lagos bat virus were recently
recovered from fruit bats in South Africa after an apparent
absence of this virus for 13 years. The sporadic occurrence
of cases is likely due to inadequate surveillance programs
for lyssavirus infections among bat populations in Africa. 
S
ince 2003, we have embarked on a passive surveillance
study to collect and identify bats with neurologic dis-
ease signs that may indicate encephalitis due to lyssavirus
infection. Consequently, 3 new cases of Lagos bat virus
(LBV) infection in fruit bats were identified in South
Africa, 1 each in 2003, 2004, and 2005. LBV is a member
of the Lyssavirus genus in the Rhabdoviridae family.
Rabies virus (RABV) was first isolated as a unique virus
within this group. However, after the isolation of rabies-
related viruses in Africa and Europe in the mid-1950s, the
Lyssavirus genus was created, and rabies virus (genotype
1) was designated as the type-species member of the
genus. At least 7 different major Lyssavirus species (geno-
types) are recognized (1), but the genus will be expanded
to include organisms isolated from Eurasia in recent years
(2). At present, 4 Lyssavirus species (genotypes) are recog-
nized in Africa. Of these, RABV (genotype 1) occurs
worldwide, but LBV (genotype 2), Mokola virus (geno-
type 3), and Duvenhage virus (genotype 4) have not been
encountered outside of Africa. Although RABV infection
of bats is well known in the Americas, this virus has only
been associated with infections of terrestrial mammals on
the African continent. Mokola virus has also been isolated
only from various terrestrial species, never bats (3). Both
LBV and Duvenhage virus are thought to be bat viruses,
although LBV infections of terrestrial animals have been
reported (4,5). RABV is a zoonotic agent throughout
Africa; Duvenhage virus and Mokola virus, but not LBV,
have also been responsible for rare zoonotic events (3,6).
LBV was first isolated from a fruit bat in 1956 in
Nigeria (7), but not until 1970 was it identified as a rabies-
related virus (8). Since then (and before this report), 11
more isolations of LBV were made throughout Africa
(Table 1), including 5 isolates from South Africa.
The Case
In June 2003, an Epomophorus wahlbergi carcass was
recovered in Durban, KwaZulu-Natal, after the bat was
caught by a domestic cat. In August 2004, a resident of
Umbilo, Durban, found a dead E. wahlbergi fruit bat on
her lawn one morning after hearing squeaking noises
around the house during the night. The fluorescent-anti-
body test (FAT), performed on brain material, was positive
for lyssavirus antigens, and virus was isolated in both
cases when suckling mice died 9–14 days after intracere-
bral injection with brain suspensions. Antigenic typing was
carried out with a panel of anti-lyssavirus nucleocapsid
monoclonal antibodies (prepared by the Centre of
Expertise for Rabies, Canadian Food Inspection Agency,
Nepean, Ontario, Canada). These analyses identified both
new isolates as LBV (genotype 2) (Table 2). Additional
characterization was accomplished by polymerase chain
reaction (PCR) and sequencing of a 457-bp region of the
nucleoprotein-encoding gene with a novel set of PCR and
sequencing primers specific for LBV (LagNF (5′-
GGGCAGATATGACGCGAGA-3′) and LagNR (5′-
TTGACCGGGTTCAAACATC-3′). Briefly, total RNA
was extracted from infected tissue by using TRIzol
(Invitrogen, Croningen, the Netherlands) according to the
manufacturer’s instructions. Complementary DNA was
produced by a reverse transcription reaction (RT) and used
in subsequent PCR. PCR products were purified by using
the Wizard SV PCR and Gel purification kit (Promega,
Madison, WI, USA). The purified products were then
sequenced by using the Big Dye Termination Cycle
Sequencing Ready Reaction Kit 3.1 (Applied Biosystems,
Foster City, CA, USA), according to the manufacturer’s
protocol, with subsequent analysis on an Applied
Biosystems 377 DNA automated sequencer.
In June 2005, a caretaker/gardener at a communal out-
door sports complex in the Bluff, Durban, found a bat on
the lawns of the complex. At the time, birds were picking
at it, and on closer inspection, it was found to be an immo-
bile adult animal with a pup attached to it. The caretaker
collected both bats and placed them in a nearby tree. Later,
the bats, still attached to each other, were again found on
the ground, where eyewitnesses also saw a cat toying with
it. The animals were then presented to a local bat rehabili-
tator. The adult animal died and was submitted for diag-
nostic testing, but results of FAT carried out on brain
smears were repeatedly negative. The pup had at least 1
evident bite wound, presumably from the cat, but other-
wise appeared healthy and was cared for by the rehabilita-
tor. Although the pup was reported to be feeding and doing
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21, 2005. By this time, RT-PCR and nucleotide sequencing
assays, carried out as described above, showed LBV in
brain material from the adult. Antigenic typing was not
performed because the level of lyssavirus antigen in the
brain matter was undetectable. In the meantime, the car-
cass of the pup was recovered, and brain material was sub-
jected to FAT and diagnostic RT-PCR. Although the
RT-PCR results were inconclusive, the FAT results were
negative.
DNAsequencing information from each case was com-
pared with nucleoprotein sequence information for LBV
and other lyssavirus species (genotypes) available in the
public domain (GenBank). ClustalW was used to produce
sequence alignments and generate a phylogenetic tree
(Figure). A graphic representation of the trees was con-
structed with the TreeView program. In this phylogeny, the
3 new LBV isolates segregate together with previously
identified LBV isolates from Ethiopia (AY333110) (7) and
Nigeria (U22842) (5). The recent isolates from South
Africa share a close sequence homology with the isolate
from Ethiopia. This finding warrants further investigation. 
Conclusions
Although LBV is rare and has not been reported in
South Africa in 13 years, a small-scale passive surveillance
effort in KwaZulu-Natal, South Africa, enabled us to iden-
tify 3 new isolations of LBV in a relatively short time. This
finding reemphasizes our lack of understanding of the true
prevalence of lyssaviruses in Africa because of poor sur-
veillance for non-rabies viruses (and, in fact, RABV)
throughout the continent. Human infections with LBV
have not been documented to date; however, this virus has
been reported in domestic animals (2 cats [4] and a dog
[5]). We describe close contact between humans and other
animals and LBV-infected bats. Cross-neutralization data
obtained in rodent models show that rabies preexposure
and postexposure prophylaxis is unlikely to be effective
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be present in bat populations; consequently, we recom-
mend appropriate precautions and use of proper personal
protection equipment, such as gloves, when interacting
with these animals. Even though the value of rabies vacci-
nation is doubtful, it should be considered in light of the
potential for cross-reactivity (15) and the lack of alterna-
tives. Surveillance should be maintained as part of a strat-
egy to better understand the epidemiology of LBV.
Cumulatively, all available evidence indicates that LBV is
likely persistently maintained in Megachiroptera popula-
tions in South Africa and other African countries where
LBV has been reported in the past.
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Figure. A neighbor-joining tree comparing 457 nucleotides of the
nucleoprotein-encoding genes of the new Lagos bat isolations
made in South Africa (bat 2003 [DQ201178], 2004 [DQ201179],
and 2005 [DQ201180]) with representative sequences of the 7
genotypes of lyssaviruses obtained from GenBank. GenBank
accession numbers are indicated on the figure. The bootstrap val-
ues were determined with 1,000 replicates.
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